Dr. Matthew Boente MD is a physician specializing in Obstetrics and Gynecology and Gynecologic Oncology. Dr. Boente has had academic administrative appointments in various medical institutions, including the Fox Chase Cancer Center, Methodist Hospital, University of Minnesota, and Minneapolis CCOP.
Dr. Matthew Boente MD is a member of various professional societies, including the American Medical Association, American Association for Cancer Research, American Society of Clinical Oncology, Gynecology Oncology Group, International Gynecologic Oncology Society, Mid-Atlantic Gynecologic Oncology Society, and Society of Surgical Oncologists.
From 2002 to 2015, Dr. Matthew Boente MD was among the recipients of Minneapolis-St. Paul Magazine’s Top Doctors Award and Minnesota Monthly’s Best Doctors for Women. His years of invaluable work in his specialization serve as the backbone of his medical career. Dr. Boente worked as an Associate Professor for the Division of Gynecologic Oncology at Duke University from 1991 to 1993 and the University of Minnesota from 2001 to 2004. During his stint as Medical Director for U.S. Medical Affairs, Gyn-Oncology at Genentech Inc. in San Francisco, Dr. Boente led a large global cross-functional team responsible for the FDA approval of bevacizumab with chemotherapy in front line ovarian cancer.
Dr Matthew Boente MD 